Prostate Cancer - Results from #100

The Prostate Cancer Foundation and Robert F. Smith Announce New Effort to Address Health Disparities for African American Men July 21, 2020

Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer. July 21, 2020

Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. July 21, 2020

African-American survivors of prostate cancer: a meta-synthesis of qualitative studies. July 21, 2020

Prostate Cancer 2020: "The Times They Are a'Changing". July 21, 2020

Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone. July 21, 2020

Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer. July 21, 2020

Largest-Ever Study of Prostate Cancer Genomics in Black Patients IDs Potential Targets for Precision Therapies July 20, 2020

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study July 20, 2020

Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH. July 20, 2020

Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence. July 20, 2020

The DNA methylation landscape of advanced prostate cancer. July 20, 2020

Rectal and Urethro-vesical Subregions for Toxicity Prediction After Prostate Cancer Radiotherapy: validation of voxel-based models in an independent population. July 20, 2020

Phase 3 HERO Trial Finds Relugolix to Be Superior to Leuprolide in Prostate Cancer. July 20, 2020

Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer. July 20, 2020

Novel PET imaging methods for prostate cancer. July 20, 2020

The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. July 20, 2020

A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy. July 20, 2020

Expression of UDP Glucuronosyltransferases 2B15 and 2B17 Is Associated with Methylation Status in Prostate Cancer cells. July 20, 2020

A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone (D4A) in human plasma. July 17, 2020

Page 6 of 1094